Author:
Feun L G,Marini A,Walker G,Elgart G,Moffat F,Rodgers S E,Wu C J,You M,Wangpaichitr M,Kuo M T,Sisson W,Jungbluth A A,Bomalaski J,Savaraj N
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Ascierto PA, Scala S, Castello G, Daponte A, Simeone E, Ottaiano A, Beneduce G, De Rosa V, Izzo F, Melucci MT, Ensor CM, Prestayko AW, Holtsberg FW, Bomalaski JS, Clark MA, Savaraj N, Feun LG, Logan TF (2005) Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies. J Clin Oncol 23: 7660–7668
2. Bowles TL, Kim R, Galante J, Parsons CM, Virudachalam S, Kung HJ, Bold RJ (2008) Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase. Int J Cancer 123: 1950–1955
3. Curley SA, Bomalaski JS, Ensor CM, Holtsberg FW, Clark MA (2003) Regression of hepatocellular cancer in a patient treated with arginine deiminase. Hepatogastroenterology 50: 1214–1216
4. Dillon BJ, Prieto VG, Curley SA, Ensor CM, Holtsberg FW, Bomalaski JS, Clark MA (2004) Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: a method for identifying cancers sensitive to arginine deprivation. Cancer 100: 826–833
5. Dinh V, You M, Savaraj N, Wu C, Kuo M, Wangpaichitr M, Feun L (2011) Determining argininosuccinate synthetase (ASS) expression in patients with melanoma treated with arginine depleting therapy. Proc Am Soc Clin Oncol 29: 661s (abstract no. 10627)
Cited by
100 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献